NCT05617014

Alzheimer's Disease Neuroimaging Initiative 4

ENROLLING_BY_INVITATIONOBSERVATIONAL

Trial Details

Start: 2023-06-09Est. Completion: 2027-07-31

Enrollment target: 1,500 participants

Locations

University of Alabama at Birmingham, Birmingham, Alabama, United States
Banner Alzheimer's Institute, Phoenix, Arizona, United States
Barrow Neurological Institute, Phoenix, Arizona, United States
Banner Sun Health Research Institute, Sun City, Arizona, United States
University of California, Irvine, Irvine, California, United States
University of California, San Diego, La Jolla, California, United States
University of California, Los Angeles, Los Angeles, California, United States
University of Southern California, Los Angeles, California, United States
Stanford University, Palo Alto, California, United States
University of California, San Francisco, San Francisco, California, United States
University of California, Davis, Walnut Creek, California, United States
Yale University, New Haven, Connecticut, United States
Georgetown University, Washington D.C., District of Columbia, United States
Howard University, Washington D.C., District of Columbia, United States
Mayo Clinic, Jacksonville, Jacksonville, Florida, United States

ICU Acquired WeaknessSepsisShockCritical IllnessMicrocirculation

This study aims to investigate how sepsis and critical illness can impair the cardiovascular system and microcirculation…

Winnipeg, CanadaEst. completion Dec 2029

Mild Cognitive Impairment

This is a double-blind, randomized controlled trial designed to test the effects of cannabidiol (CBD) on validated bioma…

Aurora, United StatesEst. completion Apr 2028

MicrobiomeTrials does not provide medical advice. Always consult your doctor before joining a clinical trial.